Authors :
Tobias Bruenger, MS – University Cologne, Germany; Eduardo Pérez-Palma, PhD – Universidad del Desarrollo, Centro de Genética y Genómica, Facultad de Medicina Clínica Alemana. Santiago, Chile; Ludovica Montanucci, PhD – Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44106, USA; Marie Macnee, MS – Cologne Center for Genomics (CCG), University of Cologne, Cologne, 50931, Germany; Alina Ivaniuk, MD – Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44106, USA; Chiara Klöckner, MD – Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.; Arthur Stefanski, MS – Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44106, USA; Nisha Bhattarai, PhD – Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.; Johannes Lemke, MD – Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.; Ingo Helbig, MD – Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. The Epilepsy NeuroGenetics Initiative (ENGIN), Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Stephanie Schorge, PhD – Department of Neuroscience, Physiology and Pharmacology, UCL, London WC1E 6BT, UK; Patrick May, PhD – Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg; Andreas Brunklaus, MD – The Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK. Institute of Health and Wellbeing, University of Glasgow, UK.; Rikke Møller, PhD – Danish Epilepsy Centre, Filadelfia, Dianalund, Denmark. Department for Regional Health Research, University of Southern Denmark, Odense, Denmark.; Dennis Lal, PhD – Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44106, USA